Healthcare provider profile · identity verified

Brian Timothy Malyon, MD

Family Practice · RED WING, MN · NPI 1629043070

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	612	189
Amlodipine Besylate	Amlodipine Besylate	361	111
Lisinopril	Lisinopril	344	101
Metoprolol Tartrate	Metoprolol Tartrate	315	89
Losartan Potassium	Losartan Potassium	306	91
Omeprazole	Omeprazole	290	83
Levothyroxine Sodium	Levothyroxine Sodium	255	72
Simvastatin	Simvastatin	226	69
Furosemide	Furosemide	187	63
Metoprolol Succinate	Metoprolol Succinate	185	57
Hydrochlorothiazide	Hydrochlorothiazide	171	52
Gabapentin	Gabapentin	164	57
Metformin Hcl	Metformin Hcl	164	44
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	161	44
Tamsulosin Hcl	Tamsulosin Hcl	160	47
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	137	42
Allopurinol	Allopurinol	124	35
Glipizide Er	Glipizide	119	35
Metformin Hcl Er	Metformin Hcl	118	37
Lovastatin	Lovastatin	116	31
Warfarin Sodium	Warfarin Sodium	115	32
Duloxetine Hcl	Duloxetine Hcl	106	27
Albuterol Sulfate Hfa	Albuterol Sulfate	97	50
Eliquis	Apixaban	93	27
Trazodone Hcl	Trazodone Hcl	91	29
Escitalopram Oxalate	Escitalopram Oxalate	86	25
Rosuvastatin Calcium	Rosuvastatin Calcium	85	27
Pravastatin Sodium	Pravastatin Sodium	80	23
Sertraline Hcl	Sertraline Hcl	79	23
Glipizide	Glipizide	77	22
Atenolol	Atenolol	72	20
Pantoprazole Sodium	Pantoprazole Sodium	66	19
Fluticasone Propionate	Fluticasone Propionate	60	27
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	57	15
Ventolin Hfa	Albuterol Sulfate	57	17
Spironolactone	Spironolactone	55	16
Potassium Chloride	Potassium Chloride	52	16
Clopidogrel	Clopidogrel Bisulfate	51	16
Finasteride	Finasteride	49	15
Jardiance	Empagliflozin	47	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	46	18
Nitroglycerin	Nitroglycerin	46	33
Montelukast Sodium	Montelukast Sodium	44	14
Triamcinolone Acetonide	Triamcinolone Acetonide	42	28
Paroxetine Hcl	Paroxetine Hcl	40	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	suppressed
Torsemide	Torsemide	37	11
Citalopram Hbr	Citalopram Hydrobromide	36	suppressed
Clonazepam	Clonazepam	36	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	36	12
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Oxycodone Hcl	Oxycodone Hcl	34	11
Carvedilol	Carvedilol	31	suppressed
Famotidine	Famotidine	31	11
Ozempic	Semaglutide	31	suppressed
Prednisone	Prednisone	29	16
Tramadol Hcl	Tramadol Hcl	28	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	27	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Celecoxib	Celecoxib	24	suppressed
Januvia	Sitagliptin Phosphate	24	suppressed
Lorazepam	Lorazepam	24	11
Terazosin Hcl	Terazosin Hcl	24	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Incruse Ellipta	Umeclidinium Bromide	21	suppressed
Pregabalin	Pregabalin	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	20
Gavilyte-G	Peg3350/Sod Sulf,bicarb,cl/Kcl	20	19
Dulera	Mometasone/Formoterol	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Amoxicillin	Amoxicillin	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Methylprednisolone	Methylprednisolone	16	16
Naproxen	Naproxen	16	suppressed
Ropinirole Hcl	Ropinirole Hcl	15	suppressed
Trulicity	Dulaglutide	15	suppressed
Valsartan	Valsartan	15	suppressed
Xarelto	Rivaroxaban	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Gavilyte-C	Peg3350/Sod Sulf,bicarb,cl/Kcl	14	12
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Cefdinir	Cefdinir	13	11
Valproic Acid	Valproic Acid	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Nystatin	Nystatin	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dextroamphetamine Sulfate Er	Dextroamphetamine Sulfate	11	suppressed
Diazepam	Diazepam	11	suppressed
Epinephrine	Epinephrine	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Gemfibrozil	Gemfibrozil	11	suppressed
Glimepiride	Glimepiride	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error